Jan Astermark

A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study

Jan Astermark, Sharyne Donfield, Donna DiMichele et al. · Blood · 2006 · 471 citations · Full text

Medicine, Hematology, Pharmacotherapy +13

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B

Steven W. Pipe, Frank W.G. Leebeek, Michael Recht et al. · New England Journal of Medicine · 2023 · 343 citations · Full text

Medicine, Hematology, Molecular Medicine +16

Break‐through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

P. Collins, Victor S. Blanchette, Kathelijn Fischer et al. · Journal of Thrombosis and Haemostasis · 2008 · 324 citations

Medicine, Hematology, Hemostasis +12

Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized

Jan Astermark, Pia Petrini, Lilian Tengborn et al. · British Journal of Haematology · 1999 · 280 citations · Full text

Medicine, Hematology, Pediatrics +13

Consensus perspectives on prophylactic therapy for haemophilia: summary statement

Erik Berntorp, Jan Astermark, Sven Björkman et al. · Haemophilia · 2003 · 270 citations · Full text

Medicine, Hematology, Pharmacotherapy +12